92 related articles for article (PubMed ID: 3281173)
1. Effect of fenfluramine on insulin/growth hormone ratio in obese subjects.
Altomonte L; Zoli A; Ghirlanda G; Manna R; Greco AV
Pharmacology; 1988; 36(2):106-11. PubMed ID: 3281173
[TBL] [Abstract][Full Text] [Related]
2. Effect of fenfluramine on growth hormone and prolactin secretion in obese subjects.
Altomonte L; Zoli A; Alessi F; Ghirlanda G; Manna R; Greco AV
Horm Res; 1987; 27(4):190-4. PubMed ID: 3436616
[TBL] [Abstract][Full Text] [Related]
3. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
[TBL] [Abstract][Full Text] [Related]
4. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
Cordido F; Dieguez C; Casanueva FF
J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
[TBL] [Abstract][Full Text] [Related]
5. Depending on the stimulus, central serotoninergic activation by fenfluramine blocks or does not alter growth hormone secretion in man.
Casanueva FF; Villanueva L; Peñalva A; Cabezas-Cerrato J
Neuroendocrinology; 1984 Apr; 38(4):302-8. PubMed ID: 6374488
[TBL] [Abstract][Full Text] [Related]
6. The effect of hypocaloric diet with and without D-fenfluramine treatment on growth hormone release after growth hormone-releasing factor stimulation in patients with android obesity.
Medeiros-Neto G; Lima N; Perozim L; Pedrinola F; Wajchenberg BL
Metabolism; 1994 Aug; 43(8):969-73. PubMed ID: 8052154
[TBL] [Abstract][Full Text] [Related]
7. Impaired growth hormone response to insulin-induced hypoglycaemia in obese patients: restoration blocked by ritanserin after fenfluramine administration.
Bernini GP; Argenio GF; Vivaldi MS; Del Corso C; Birindelli R; Luisi M; Franchi F
Clin Endocrinol (Oxf); 1990 Apr; 32(4):453-9. PubMed ID: 2112069
[TBL] [Abstract][Full Text] [Related]
8. Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity.
Maccario M; Grottoli S; Razzore P; Procopio M; Oleandri SE; Ciccarelli E; Camanni F; Ghigo E
Eur J Endocrinol; 1996 Aug; 135(2):205-10. PubMed ID: 8810734
[TBL] [Abstract][Full Text] [Related]
9. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
[TBL] [Abstract][Full Text] [Related]
10. In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose.
Maccario M; Procopio M; Grottoli S; Oleandri SE; Razzore P; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1995 Dec; 80(12):3774-8. PubMed ID: 8530634
[TBL] [Abstract][Full Text] [Related]
11. Insulin and growth hormone in lean and obese pigs.
Wangsness PJ; Martin RJ; Gahagan JH
Am J Physiol; 1977 Aug; 233(2):E104-8. PubMed ID: 888946
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis of GH deficiency in obese patients: a reappraisal with GHRH plus arginine testing after pharmacological blockade of lipolysis.
Scacchi M; Orsini F; Cattaneo A; Grasso A; Filippini B; Pecori Giraldi F; Fatti LM; Moro M; Cavagnini F
Eur J Endocrinol; 2010 Aug; 163(2):201-6. PubMed ID: 20460421
[TBL] [Abstract][Full Text] [Related]
13. Restoration of growth hormone (GH) response to GH-releasing hormone in elderly and obese subjects by acute pharmacological reduction of plasma free fatty acids.
Pontiroli AE; Manzoni MF; Malighetti ME; Lanzi R
J Clin Endocrinol Metab; 1996 Nov; 81(11):3998-4001. PubMed ID: 8923850
[TBL] [Abstract][Full Text] [Related]
14. Specific stimulation of brain serotonin mediated neurotransmission by dexfenfluramine does not restore growth hormone responsiveness in obese women.
Kars ME; Pijl H; Cohen AF; Frölich M; Schoemaker HC; Brandenburg HC; Meinders AE
Clin Endocrinol (Oxf); 1996 May; 44(5):541-6. PubMed ID: 8762730
[TBL] [Abstract][Full Text] [Related]
15. Cholinergic receptor activation by pyridostigmine restores growth hormone (GH) responsiveness to GH-releasing hormone administration in obese subjects: evidence for hypothalamic somatostatinergic participation in the blunted GH release of obesity.
Cordido F; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1989 Feb; 68(2):290-3. PubMed ID: 2493023
[TBL] [Abstract][Full Text] [Related]
16. Very-low-calorie diet-induced weight reduction reverses impaired growth hormone secretion response to growth hormone-releasing hormone, arginine, and L-dopa in obesity.
Tanaka K; Inoue S; Numata K; Okazaki H; Nakamura S; Takamura Y
Metabolism; 1990 Sep; 39(9):892-6. PubMed ID: 2118219
[TBL] [Abstract][Full Text] [Related]
17. Low-dose growth hormone treatment with diet restriction accelerates body fat loss, exerts anabolic effect and improves growth hormone secretory dysfunction in obese adults.
Kim KR; Nam SY; Song YD; Lim SK; Lee HC; Huh KB
Horm Res; 1999; 51(2):78-84. PubMed ID: 10352397
[TBL] [Abstract][Full Text] [Related]
18. Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity.
Rasmussen MH; Juul A; Kjems LL; Skakkebaek NE; Hilsted J
J Clin Endocrinol Metab; 1995 Mar; 80(3):796-801. PubMed ID: 7533771
[TBL] [Abstract][Full Text] [Related]
19. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
20. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
